fda import alert green list glp-1 semaglutide tirzepatide 2025 SFDA updates guidelines for pharmaceutical variation requirements FDA sends warning letter after

When to Contact Your Healthcare Provider or Seek Urgent Care Seek urgent care for a sudden, severe headache, any new neurological signs such as: Weakness or speech change Visual loss Severe vomiting Fever Fainting A headache that is much worse than your usual one Contact your prescriber if you have frequent headaches after starting tirzepatide, recurrent hypoglycemia, or if you are on insulin, sulfonylureas, or blood pressure medicines and suspect those doses need adjustment

Improved blood sugar control Originally developed to manage diabetes, GLP-1 medications promote stable glucose levels through increased insulin output

Explained In the realm of medical breakthroughs, few substances have stirred as much excitement and intrigue as Semaglutide

Dr Amanda Lim, a consultant in the division of endocrinology at the National University Hospital, noted that previously, lifestyle interventions might result in weight loss of around 3 to 8 per cent